pone.0204646.g001.tif (781.05 kB)

Patient disposition.

Download (781.05 kB)
posted on 15.11.2018, 18:36 by Bernard A. Zonnenberg, Maureen P. Neary, Mei Sheng Duh, Raluca Ionescu-Ittu, Jonathan Fortier, Francis Vekeman

1 Please see Table 1 for criteria used to define rAML stage. 2 For the kidney size outcome, potential index dates were selected from days with kidney size assessments (with an MRI or CT sca); for the kidney function outcome potential index dates were selected from days with creatinine assessments. 3 For a given patient and a given outcome, if multiple potential index dates were available, a single index date was selected based on time at which the patient was the most likely to be treated with everolimus (probability of everolimus treatment was estimated from a logistic regression model including the following covariates: age at index date and eGFR and size of the largest kidney at the index date).